Photo from wikipedia
Thyrotropin (TSH) suppression therapy is a standard treatment after surgery for differentiated thyroid carcinoma (DTC). It may be associated with osteoporosis in postmenopausal women. However, there are no guidelines for… Click to show full abstract
Thyrotropin (TSH) suppression therapy is a standard treatment after surgery for differentiated thyroid carcinoma (DTC). It may be associated with osteoporosis in postmenopausal women. However, there are no guidelines for bone mineral density (BMD) testing intervals to screen for osteoporosis in these patients. Therefore, we evaluated the timing of repeated BMD testing in DTC patients with TSH suppression according to baseline T‐scores.
Keywords:
tsh suppression;
suppression therapy;
thyroid carcinoma;
differentiated thyroid;
osteoporosis;
suppression
Journal Title: Clinical Endocrinology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical Endocrinology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!